13-R398

2013 -- S 0537 SUBSTITUTE A

Enacted 07/11/13

 

 

J O I N T R E S O L U T I O N

RESPECTFULLY REQUESTING THE OFFICE OF THE HEALTH INSURANCE COMMISSIONER TO ENSURE THAT RHODE ISLAND INSURERS COVER TOPICAL OPHTHALMIC TREATMENT EARLY REFILLS IN A MANNER SIMILAR TO OR CONSISTENT WITH CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS)

GUIDELINES FOR ALL COVERED INDIVIDUALS

     

     

     Introduced By: Senators Felag, Lynch, Ciccone, Lombardi, and Ottiano

     Date Introduced: February 28, 2013

 

 

     WHEREAS, According to the World Health Organization (WHO), there are an estimated

45 million persons with open angle glaucoma and this figure is projected to rise to 59 million

respectively by 2020; and

     WHEREAS The National Eye Institute estimates the prevalence of open angle glaucoma

in the U.S. population aged 40 and older at 1.86 percent;

     WHEREAS Increased risk factors for open angle glaucoma include age, family history,

national heritage (for example African American or Latino American heritage), having had

serious eye injury or eye surgery in the past, or the taking of a corticosteroid medication;

     WHEREAS, Early detection and treatment is critical to preventing serious vision loss as a

result of glaucoma;

     WHEREAS, Eye drops are often used in the treatment of certain chronic diseases such as

glaucoma;

     WHEREAS, Eye drops are also used to reduce the risk of infection, reduce inflammation

after surgeries, and to relieve conjunctivitis and dry eyes;

     WHEREAS, This General Assembly strongly supports early refill of prescription eye

drops necessary to ensure continued access to effective treatments for individuals with eye

diseases;

     WHEREAS, The Centers for Medicare & Medicaid Services (CMS) have issued

regulations that authorize refills, for inadvertent spillage at a rate of 70% in a 30 day time period,

allowing patients to refill at day 21 for the essential topical ophthalmic treatments; and

     WHEREAS, The major insurers in Rhode Island have provided written assurances that

their pharmacy policies allow for early refills similar to or consistent with the CMS regulations;

and

     WHEREAS, Health care professionals interested in ensuring proper dosage for treatment

of eye disease may work with pharmaceutical companies that manufacture and distribute

ophthalmic products to seek additional safeguards and allowances for spillage by patients,

including our most vulnerable populations;

     WHEREAS, Rhode Island healthcare providers and pharmacists may work together to

continue to inform patients about coverage for early refill of medication and proper usage as

prescribed and needed to ensure effective treatment and positive health outcomes; and

     WHEREAS, While the Patient Protection and Accountability Act (PPACA) allows states

to mandate health benefits for qualified health plans; however, effective January 1, 2014, the

PPACA will assess costs to the states for additional benefits that are mandated after December

31, 2011; now therefore be it

     RESOLVED, The General Assembly respectfully requests that the Office of the Health

Insurance Commissioner continues to ensure that Rhode Island insurers cover topical ophthalmic

treatment early refills in a manner similar to or consistent with the Centers for Medicare &

Medicaid Services regulations for all covered individuals; and be it further

     RESOLVED, That the Secretary of State be and is hereby authorized and directed to

transmit duly certified copies of this resolution to the Governor, the Director of the Department of

Health, the Office of the Health Insurance Commissioner, the Rhode Island Society of Eye

Physicians and Surgeons, and the Rhode Island Medical Society.

     

=======

LC01311/SUB A

========